BNY Mellon IM expands thematic range with healthcare biotech fund
Third fund in range
The fund will invest in companies developing gene therapy, gene editing and gene modulation treatments
BNY Mellon Investment Management has added a fund focused on healthcare biotechnology to its innovation fund range, to be managed by Mellon Investments Corporation.
The BNY Mellon Smart Cures Innovation fund is part of the Irish-domiciled fund range, BNY Mellon Global Funds, with Mellon's Amanda Birdsey-Benson and Matthew Jenkin named as co-managers. It will invest...
More on Equities
Back to Top
